Despite growing interest from both patients and healthcare providers, there is little clinical guidance on how mobile apps should be utilized to add value to patient care. We categorize apps according to their functionality (e.g. preventative behavior change, digital self-management of a specific condition, diagnostic) and discuss evidence for effectiveness from published systematic reviews and meta-analyses and the relevance to patient care. We discuss the limitations of the current literature describing clinical outcomes from mHealth apps, what FDA clearance means now (510(k)/de novo FDA clearance) and in the future. We discuss data security and privacy as a major concern for patients when using mHealth apps. Patients are often not involved in the development of mobile health guidelines, and professionals' views regarding high-quality health apps may not reflect patients' views. We discuss efforts to develop guidelines for the development of safe and effective mHealth apps in the US and elsewhere and the role of independent app reviews sites in identifying mHealth apps for patient care. There are only a small number of clinical scenarios where published evidence suggests that mHealth apps may improve patient outcomes.

中文翻译：

---

移动健康对患者有什么临床价值？

尽管患者和医疗保健提供者的兴趣日益浓厚，但关于如何利用移动应用程序为患者护理增加价值的临床指南却很少。我们根据应用程序的功能（例如预防性行为改变、特定状况的数字化自我管理、诊断）对应用程序进行分类，并讨论已发表的系统评价和荟萃分析的有效性证据以及与患者护理的相关性。我们讨论了当前描述 mHealth 应用程序临床结果的文献的局限性、FDA 许可现在（510(k)/从头 FDA 许可）和未来意味着什么。我们讨论数据安全和隐私是患者在使用移动医疗应用程序时主要关心的问题。患者通常不参与移动健康指南的制定，专业人士对高质量健康应用程序的看法可能并不反映患者的观点。我们讨论了在美国和其他地方为开发安全有效的移动医疗应用程序制定指南的努力，以及独立应用程序评论网站在确定用于患者护理的移动医疗应用程序方面的作用。只有少数临床场景已发表的证据表明移动医疗应用程序可以改善患者的治疗结果。